Tissue-Pathway Peptides
ARA290
An 11-residue peptide from the helix-B region of erythropoietin, supplied as a sealed lyophilized vial for receptor research.
10mg
View Details
Tissue-Pathway Peptides
BPC-157 and TB-500 combined at equal nominal mass in one sealed lyophilized vial, for comparative and compatibility research.
Research use only
This entry combines BPC-157 and TB-500 at equal nominal mass in a single lyophilized vial. Because it is a two-component blend, no single CAS number, molecular weight, or formula applies to the vial as a whole; the specification for a given batch is set out in that batch's documentation.
Laboratories reference this combination for controlled in-vitro comparison between the two peptides, for analytical verification of each component, and for studies of how the components behave together in a shared preparation.
The vial is sealed after freeze-drying and labeled with its total nominal mass. Ask for the relevant batch documentation when you inquire about this product.
| Purity | See batch documentation |
|---|---|
| CAS number | See batch documentation |
| Molecular weight | See batch documentation |
| Molecular formula | See batch documentation |
| Material class | Two-component peptide blend |
| Appearance | White to off-white lyophilized powder |
| Available vial sizes | 10mg total |
| Documentation | Batch documentation confirmed on request |